High-dose chemotherapy and immunotherapy
β
Albert Oriol; Josep-Maria Ribera; Juan Bergua; Eduardo GimΓ©nez Mesa; Carlos Gran
π
Article
π
2008
π
John Wiley and Sons
π
English
β 160 KB
## Abstract ## BACKGROUND. It has been recognized that cure is possible for human immunodeficiency virus (HIV)βinfected patients with Burkitt lymphoma/leukemia (BL) if appropriate chemotherapy is used. The introduction of rituximab in BL therapeutic schemes has been scarcely explored. The outcome